Imman I. Hosseini

Imman I. Hosseini

Auto-generated profile, based on publicly available information

Imman I. Hosseini

Department of Bioengineering, McGill University, Montreal, Canada

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2023 in Nature Nanotechnology
Verified
Journal Article
Closed access
PDF file
TATamer AbdElFatah
Tamer AbdElFatah
MJMahsa Jalali
Mahsa Jalali
SYSripadh Guptha Yedire
Sripadh Guptha Yedire
IHImman I. Hosseini
Imman I. Hosseini
CMCarolina del Real Mata
Carolina del Real Mata
SMSara Mahshid
Sara Mahshid

2 February 2026 in Nature Nanotechnology
Verified
Journal Article
Closed access
PDF file
MJMahsa Jalali
Mahsa Jalali
TATamer AbdElFatah
Tamer AbdElFatah
CMCarolina del Real Mata
Carolina del Real Mata
IHImman I. Hosseini
Imman I. Hosseini
SYSripadh Guptha Yedire
Sripadh Guptha Yedire
SMSara Mahshid
Sara Mahshid

11 July 2025 in ECS Meeting Abstracts
Verified
Journal Article
Closed access
RMRoozbeh Siavash Moakhar
Roozbeh Siavash Moakhar
TFTamer Abdel Fatah
Tamer Abdel Fatah
MJMahsa Jalali
Mahsa Jalali
SYSripadh Guptha Yedire
Sripadh Guptha Yedire
CMCarolina del Real Mata
Carolina del Real Mata
DNDao Nguyen
Dao Nguyen
Antimicrobial resistance (AMR) poses a significant global health threat by undermining the effectiveness of antibiotics and compromising the ability to treat bacterial infections. The urgent demand for innovative diagnostic tools has intensified interest in rapid antibiotic susceptibility testing (AST) technologies. Conventional AST methods are typically time-intensive, relying on prolonged bacterial cultures to determine antibiotic response. Rapid AST methods are crucial for enabling timely and precise antibiotic therapies, minimizing inappropriate antibiotic usage, and slowing the advancement of resistance. In this study, we present an electrochemical platform for AST that utilizes nanostructured electrodes and diverse cell viability assays to accurately determine bacterial viability in response to antibiotics. By integrating multiple viability assays with electrochemical analysis, our platform provides a comprehensive assessment of bacterial survival under antibiotic treatment. This approach not only enhances detection accuracy but also accelerates the determination of antibiotic susceptibility. The combination of advanced nanotechnology, and multi-assay integration in our device underscores its potential as a next-generation AST tool.

9 August 2024 in ECS Meeting Abstracts
Verified
Journal Article
Closed access
SHSeyed Vahid Hamidi
Seyed Vahid Hamidi
IHImman I. Hosseini
Imman I. Hosseini
RMRoozbeh Siavash Moakhar
Roozbeh Siavash Moakhar
AJArash Khorrami Jahromi
Arash Khorrami Jahromi
SMSara Mahshid
Sara Mahshid
Multivalent aptamers have gained substantial interest owing to their enhanced affinity towards target analytes compared to their monomeric counterparts due to their capability to bind simultaneously to diverse regions of a target molecule, fostering more robust and enduring interactions. This study focuses on engineering the surface-based production and modification of multivalent aptamers through room temperature rolling circle amplification technique and chemically modified primers. This process starts with immobilizing modified primers onto an electrode to generate and arrange biosynthesised multivalent aptamers. These bio-engineered multivalent aptamers are utilized as bio-receptors for capturing a specific target (in this case, the SARS-CoV-2 spike protein). The entire surface amplification procedure is extensively characterized using electrochemical, microscopy, and spectroscopy methods, determining the optimal amplification duration for biosensing applications. Impressively, multivalent aptasensors shows substantially increased response signals and affinity compared to monomeric aptasensors. Moreover, the influence of surface structures on response signals is explored by employing both flat screen-printed gold electrodes and nano-/microisland (NMI) electrodes. NMIs-based multimeric aptasensors demonstrate notably heightened sensitivity in detecting SARS-CoV-2 spike protein within the range of 10 to 106 fg/mL in saliva and buffer media. Finally, the signal of the proposed aptasensor has been successfully assessed using several patient samples.